Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001726100-17-000001
Filing Date
2017-12-22
Accepted
2017-12-22 13:49:11
Documents
1
Effectiveness Date
2017-12-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7551
  Complete submission text file 0001726100-17-000001.txt   8595
Mailing Address 9000 CROW CANYON ROAD, STE. 620 DANVILLE CA 94506
Business Address 9000 CROW CANYON ROAD, STE. 620 DANVILLE CA 94506 (925) 399-7246
Elysium Therapeutics, Inc. (Filer) CIK: 0001726100 (see all company filings)

EIN.: 462769808 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-301555 | Film No.: 171272196